J&J CEO downplays any need for ‘large’ acquisition as it gears up for new launchesnews2025-10-14T17:41:05+00:00October 14th, 2025|Endpoints News|
Krystal Biotech wins second-ever FDA platform designation for viral vectornews2025-10-14T17:38:16+00:00October 14th, 2025|Endpoints News|
Supreme Court passes on fight over FDA stem cell regulationnews2025-10-14T16:07:37+00:00October 14th, 2025|Endpoints News|
A gene therapy pioneer reckons with the reality for ultra-rare diseasesnews2025-10-14T15:33:45+00:00October 14th, 2025|Endpoints News|
BioCryst to acquire Astria for $700M, adding a second HAE drugnews2025-10-14T15:13:14+00:00October 14th, 2025|Endpoints News|
Q&A: Nobel winner Fred Ramsdell on basic research in biotech, and the future of cell therapynews2025-10-14T14:41:49+00:00October 14th, 2025|Endpoints News|
FDA delays decision on Denali drug; Astellas’ Vyloy fails mid-stage pancreatic cancer trialnews2025-10-14T14:40:28+00:00October 14th, 2025|Endpoints News|
Lila Sciences closes $350M Series A, bringing in Nvidianews2025-10-14T13:41:42+00:00October 14th, 2025|Endpoints News|
Kardigan raises $254M to test cardio drugs from Sanofi, BMS and Ionisnews2025-10-14T13:00:48+00:00October 14th, 2025|Endpoints News|
Cylinder Health adds evidence to its approach of treating GI symptomsnews2025-10-14T12:00:37+00:00October 14th, 2025|Endpoints News|
